Clinical Trial Design and Artificial Intelligence | Pepgra.com

-
Clinical trials take up the second half of the ten – 15 year, 1.5 – 2.0 billion USD, cycle of development only for introducing a replacement drug within a market. Therefore, any Clinical Trials Services that end in failure tends to translate not just in losses in terms of investment for the clinical trial but also takes into its ambit the prices incurred as preclinical development costs. 

 This renders the loss for each failed clinical test at 800 million to 1.5 billion USD(Harrer et al., 2019). Keeping these factors in mind, it might be beneficial to explore how AI or AI because it is popularly known are often effectively utilized to re-mould the key phases of a Clinical Trail design with a view to reinforce the speed of success within the trial.


Factors causing Failures in Clinical Trials and how AI can help

The main two factors that cause failure within clinical trials services pertains to the choice of patient cohorts and therefore the mechanisms used for recruiting cohorts. The said two factors aren't enough to usher in the foremost appropriate patients to the trial during a timely manner, along side the absence of a technical infrastructure to match the intricacies of executing a clinical trial(Fogel, 2018).

AI and its Evolution

AI within the domain of drugs features a history which matches back to the first 1970s when proficient systems like MYCIN had been initially introduced for providing support to diagnostic decisions(Shortliffe, 1984). Nonetheless, early systems of medical AI depended largely on experts from the medical domain for training computers by encrypting clinical knowledge as logic based rules for particular situations or scenarios. Systems of such kind were wrought with the limitation wherein it had been intensive to labour and required tons of your time for the development process. Also, once it had been developed there have been also considerable challenges with regards to any future updates intrinsically systems were largely rigid(McCauley & Ala, 1992).


AI in Clinical Trials

he figure above envisions the key techniques through which AI are often introduced within the tenets of clinical design. There are three key themes within the planning which comprises of; cohort composition, patient recruitment and patient monitoring. These are founded on the features of the patient in terms of eligibility, suitability, empowerment, enrollment and motivation. this is often also inclusive of aspects concerning trial such as; adherence control, endpoint detection and retention of patients. An array of methodologies for design has been utilized to execute functionalities of the target.

To Continue Reading blog: https://www.pepgra.com/blog/clinical-trial-design-and-artificial-intelligence/


Read More 

Clinical Trail Services
Clinical Trail Design
Clinical Study Design
Clinical Trail Study Design
Patient Monitoring Services




Comments

Post a Comment

Popular posts from this blog

Difference between Clinical Research Organization and Contract Research Organization(CRO)?

-
Image
1.  A  contract research organization (CRO) organization that offers clinical trial and all kind of research support services outsourced on a contract basis to the pharmaceutical, biotechnology, and medical device industries and also serve government institutions, foundations, and universities.  2.  While contract research organizations can span the whole pharma pipeline from drug discovery to clinical trials and beyond, a clinical research company mostly manages clinical trials. 3. A contract research organization (CRO) sometime known as clinical research organization is the company or organization that helps conduct research for a sponsor company. This research can be ranges from pre-clinical development of new products to post marketing research activities. 4. CROs Play a major Role in Drug Development   5. One of the important ICH GCP guideline is followed to conduct clinical studies 6. A clinical research company mostly manages clinical trials.   To Read More: clinical resear
Read more

THE ROLE OF REFERENCING IN SCIENTIFIC WRITING

-
Image
The Role of Referencing in Scientific Writing Scientific writing  makes up an integral element within research. Of late, the pace at which findings of a research is communicated through diverse mediums such as thesis, books, conference papers and journal articles has substantially increased with widespread developments in technology and medicine. The findings from these researches are usually perceived as harbingers of development in the academic and scientific domain, driving further research or action. As is the case in any kind of academic writing, scientific writing too warrants the need for adequate references to correlate the findings with experiments conducted in the past or to indicate what researchers have said about a particular phenomenon. As a matter of fact, referencing and bibliography are vital components within a scientific paper. This article is essentially an attempt to highlight the key features, benefits and limitations of most commonly used referencing tools
Read more

TIPS FOR SCIENTIFIC MEDICAL WRITING

-
Image
Scientific medical writing involves writing detailed information about the essential medical sciences, drugs and latest technological innovation within the field of drugs for a variety of audiences including medical specialists and health care professionals. This scientific information is written for publication within the medical journals, medical news, and regulatory documents. MEDDEV (2.7/1) guidelines for CER documentation describe the various stages of planning, assessment, and evaluation of clinical data about medical a device to validate the clinical safety and functional performance of the concerned medical device. Some of the important procedures and documents involved in the CER development process include • Standard operating procedures for carrying out Clinical Evaluation • Quality System related procedures and protocols • Outlines for Clinical Evaluation Plan (CEP) and Clinical Evaluation Report. • Pre-market and post-post market CER • Clinic
Read more